Filing Details
- Accession Number:
- 0001447362-21-000070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-07 18:15:49
- Reporting Period:
- 2021-04-05
- Accepted Time:
- 2021-04-07 18:15:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447362 | Castle Biosciences Inc | CSTL | Pharmaceutical Preparations (2834) | CA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1024008 | S David Kabakoff | C/O Castle Biosciences, Inc. 505 S. Friendswood Drive, Suite 401 Friendswood TX 77546 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-05 | 50,000 | $71.79 | 593,577 | No | 4 | S | Indirect | By L.P. |
| Common Stock | Disposition | 2021-04-05 | 20,000 | $73.22 | 573,577 | No | 4 | S | Indirect | By L.P. |
| Common Stock | Disposition | 2021-04-06 | 40,000 | $73.99 | 533,577 | No | 4 | S | Indirect | By L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By L.P. |
| No | 4 | S | Indirect | By L.P. |
| No | 4 | S | Indirect | By L.P. |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by Sofinnova HealthQuest Partners, L.P. on December 17, 2020.
- This transaction was executed in multiple trades at prices ranging from $71.1820 to $72.1647, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held by Sofinnova HealthQuest Partners, L.P., or HealthQuest Partners. HealthQuest Venture Management, L.L.C., or HealthQuest Management, is the general partner of HealthQuest Partners. David Kabakoff, Ph.D., the Reporting Person, is a partner of HealthQuest Management. Garheng Kong is the managing member of HealthQuest Management and has sole voting and investment power over the shares held by HealthQuest Partners. Each of HealthQuest Management, Mr. Kong and Dr. Kabakoff disclaims beneficial ownership over all shares held by HealthQuest Partners except to the extent of any pecuniary interest therein.
- This transaction was executed in multiple trades at prices ranging from $73.1857 to $73.2564, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $73.4821 to $74.1945, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
